Lazma Cream 30gm is a prescribed medication designed to address skin concerns. This cream combines three key components for an 8-week topical therapy targeting moderate to severe facial melasma. It comprises fluocinolone acetonide (0.01%) to reduce inflammation, hydroquinone (4%) as a depigmenting agent that lightens the skin by interrupting melanin formation, and tretinoin (0.05%) to enhance skin cell turnover, promoting exfoliation. Lazma Cream offers an effective solution for those dealing with melasma, providing a comprehensive approach to managing this skin condition.